Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1818
+0.0057 (3.24%)
At close: Aug 11, 2026, 4:00 PM EDT
0.1818
0.00 (0.00%)
Pre-market: Aug 12, 2026, 4:15 AM EDT
Gossamer Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 41.03 | 37.73 | 46.07 | 32.11 | 111.97 | 183.4 |
Short-Term Investments | 58.19 | 99.2 | 248.44 | 264.32 | 143.71 | 141.82 |
Cash & Short-Term Investments | 99.22 | 136.93 | 294.52 | 296.43 | 255.68 | 325.22 |
Cash Growth | -61.53% | -53.51% | -0.64% | 15.94% | -21.38% | -36.56% |
Other Receivables | 9.25 | 12.23 | 5.34 | - | - | - |
Total Trade Receivables | 9.25 | 12.23 | 5.34 | - | - | - |
Other Current Assets | 16.07 | 18.49 | 10.03 | 10.09 | 6.2 | 6.56 |
Total Current Assets | 124.54 | 167.64 | 309.89 | 306.52 | 261.88 | 331.78 |
Net Property, Plant & Equipment | 3.97 | 4.2 | 5.12 | 4.78 | 9.89 | 10.8 |
Other Long-Term Assets | 0.4 | 0.41 | 0.28 | 0.62 | 0.68 | 1.08 |
Total Assets | 128.9 | 172.25 | 315.29 | 311.92 | 272.45 | 343.66 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 10.82 | 5.96 | 2.32 | 5.53 | 1.46 | 3.24 |
Accrued Expenses | 36.94 | 37.49 | 25.64 | 34.46 | 36.16 | 36.62 |
Current Portion of Long-Term Debt | - | - | - | 11.61 | 11.61 | - |
Unearned Revenue | 8.74 | 19.99 | 17.05 | - | - | - |
Total Current Liabilities | 56.51 | 63.44 | 45.01 | 51.6 | 49.23 | 39.86 |
Long-Term Debt | 198.76 | 198.51 | 197.52 | 197.41 | 207.7 | 179.12 |
Long-Term Leases | 3.21 | 3.46 | 4.4 | 0.14 | 3.45 | 3.22 |
Other Long-Term Liabilities | 31.9 | 29.61 | 38.87 | - | - | - |
Total Long-Term Liabilities | 233.88 | 231.57 | 240.79 | 197.55 | 211.14 | 182.34 |
Total Liabilities | 290.38 | 295.01 | 285.8 | 249.15 | 260.37 | 222.19 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
Additional Paid-in Capital | 1,328 | 1,321 | 1,297 | 1,275 | 1,045 | 932.94 |
Accumulated Other Comprehensive Income | -4.02 | -5.15 | 1.19 | -0.35 | -0.57 | 0.05 |
Retained Earnings | -1,486 | -1,439 | -1,269 | -1,212 | -1,032 | -811.53 |
Shareholders' Equity | -161.48 | -122.76 | 29.49 | 62.77 | 12.08 | 121.46 |
Total Liabilities & Equity | 128.9 | 172.25 | 315.29 | 311.92 | 272.45 | 343.66 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 201.98 | 201.97 | 201.92 | 209.16 | 222.76 | 182.34 |
Net Cash (Debt) | -102.76 | -65.04 | 92.6 | 87.26 | 32.92 | 142.88 |
Net Cash Growth | - | - | 6.11% | 165.06% | -76.96% | -57.03% |
Net Cash Per Share | -0.45 | -0.28 | 0.41 | 0.57 | 0.39 | 1.91 |
Book Value | -161.48 | -122.76 | 29.49 | 62.77 | 12.08 | 121.46 |
Book Value Per Share | -0.71 | -0.54 | 0.13 | 0.41 | 0.14 | 1.62 |
Tangible Book Value | -161.48 | -122.76 | 29.49 | 62.77 | 12.08 | 121.46 |
Tangible Book Value Per Share | -0.71 | -0.54 | 0.13 | 0.41 | 0.14 | 1.62 |